Encephalitis Drugs Market Size & Share, by Drug Class (Acyclovir, Ganciclovir, Foscarnet); Distribution Channel {Offline (Hospital Pharmacies, Drug Stores), Online} - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

Encephalitis Drugs Market size is projected to grow at around 14.7% CAGR during the forecast period i.e., between 2025-2037.
 

The growth of the market can be attributed to the increasing prevalence of primary as well as secondary encephalitis, which is caused by viral infection. Encephalitis can be deadly as it causes swelling of the brain, speech and hearing impairments, and paralysis. It is more common in children and older population, or patients undergoing immunotherapy. Rising geriatric population, and increasing prevalence of auto-immune diseases are estimated to boost the market growth. 9.318% of the global population ages above 65 years, as of 2020, according to the statistics by the World Bank. As per the British Society of Immunology, rheumatic diseases such as rheumatoid arthritis are increasing at 7% as of 2019, while endocrinological conditions are increasing by 6.3%. The increasing investment in the R&D activities in the medical field, along with rising health awareness amongst the people is estimated to boost the market growth. Moreover, the developing public healthcare infrastructure and high government expenditure for the development of new drugs is anticipated to significantly fuel the growth of the market.